17β-Estradiol alters oxidative stress response protein expression and oxidative damage in the uterus

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 218-226

  Yuan, Lisi ^a   Dietrich, Alicia K ^a   Nardulli, Ann M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Apurinic endonuclease; Cu Zn superoxide dismutase; Estrogen receptor a script ; Oxidative stress; Protein disulfide isomerase; Thioredoxin

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; PROGESTERONE RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN DISULFIDE ISOMERASE; THIOREDOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DAMAGE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; LIPID PEROXIDATION; MOUSE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

APURINIC ENDONUCLEASE; CU/ZN SUPEROXIDE DISMUTASE; ESTROGEN RECEPTOR A; OXIDATIVE STRESS; PROTEIN DISULFIDE ISOMERASE; THIOREDOXIN;

ANIMALS; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; LIPID PEROXIDATION; MICE; MICE, INBRED C57BL; OILS; OVARIECTOMY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN DISULFIDE-ISOMERASES; PROTEIN TRANSPORT; RECEPTORS, PROGESTERONE; SUPEROXIDE DISMUTASE; THIOREDOXINS; UTERUS;

EID: 84886255467     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.09.023     Document Type: Article

References (67)

1. Arner E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 2000, 267:6102-6109.
2. Arner E.S., Holmgren A. The thioredoxin system in cancer. Semin. Cancer Biol. 2006, 16:420-426.
3. Bhakat K.K., Mantha A.K., Mitra S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid. Redox Signal. 2009, 11:621-638.
4. Cha M.K., Suh K.H., Kim I.H. Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J. Exp. Clin. Cancer Res. 2009, 28. pp. 93-9966-28-93.
5. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 1999, 20:358-417.
6. Couse J.F., Curtis S.W., Washburn T.F., Lindzey J., Golding T.S., Lubahn D.B., Smithies O., Korach K.S. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 1995, 9:1441-1454.
7. Curtis C.D., Thorngren D.L., Ziegler Y.S., Sarkeshik A., Yates J.R., Nardulli A.M. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression. Mol. Endocrinol. 2009, 23:1346-1359.
8. Curtis C.D., Thorngren D.L., Nardulli A.M. Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues. BMC Cancer 2010, 10. pp. 9-2407-10-9.
9. 2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1. Mol. Cell. Biochem. 2010, 337:53-63.
10. Deroo B.J., Hewitt S.C., Peddada S.D., Korach K.S. Estradiol regulates the thioredoxin antioxidant system in the mouse uterus. Endocrinology 2004, 145:5485-5492.
11. Dietrich A.K., Humphreys G.I., Nardulli A.M. 17beta-Estradiol increases expression of the oxidative stress response and DNA repair protein apurinic endonuclease (Ape1) in the cerebral cortex of female mice following hypoxia. J. Steroid Biochem. Mol. Biol. 2013, 138:410-420.
12. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 2001, 98:1952-1957.
13. Fu X., Wang P., Zhu B.T. Protein disulfide isomerase is a multifunctional regulator of estrogenic status in target cells. J. Steroid Biochem. Mol. Biol. 2008, 112:127-137.
14. 3H mice. J. Toxicol. Environ. Health 1984, 14:551-567.
15. Gunin A.G., Mashin I.N., Zakharov D.A. Proliferation, mitosis orientation and morphogenetic changes in the uterus of mice following chronic treatment with both estrogen and glucocorticoid hormones. J. Endocrinol. 2001, 169:23-31.
16. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
17. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem. J. 2007, 401:1-11.
18. Hatahet F., Ruddock L.W. Substrate recognition by the protein disulfide isomerases. Febs J. 2007, 274:5223-5234.
19. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87:905-931.
20. Hewitt S.C., Deroo B.J., Hansen K., Collins J., Grissom S., Afshari C.A., Korach K.S. Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol. Endocrinol. 2003, 17:2070-2083.
21. Hewitt S.C., Li L., Grimm S.A., Chen Y., Liu L., Li Y., Bushel P.R., Fargo D., Korach K.S. Research resource: whole-genome estrogen receptor alpha binding in mouse uterine tissue revealed by ChIP-Seq. Mol. Endocrinol. 2012, 26:887-898.
22. 3H mice continuously fed diets containing diethylstilbestrol or 17beta-estradiol. J. Environ. Pathol. Toxicol. 1978, 1:1-30.
23. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J. Biol. Chem. 1999, 274:27891-27897.
24. Holmgren A., Lu J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem. Biophys. Res. Commun. 2010, 396:120-124.
25. Hong S.H., Nah H.Y., Lee J.Y., Gye M.C., Kim C.H., Kim M.K. Analysis of estrogen-regulated genes in mouse uterus using cDNA microarray and laser capture microdissection. J. Endocrinol. 2004, 181:157-167.
26. Kelley M.R., Georgiadis M.M., Fishel M.L. APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1. Curr. Mol. Pharmacol. 2012, 5:36-53.
27. Klaunig J.E., Kamendulis L.M., Hocevar B.A. Oxidative stress and oxidative damage in carcinogenesis. Toxicol. Pathol. 2010, 38:96-109.
28. Korach K.S. Insights from the study of animals lacking functional estrogen receptor. Science 1994, 266:1524-1527.
29. Kurita T., Lee K., Saunders P.T., Cooke P.S., Taylor J.A., Lubahn D.B., Zhao C., Makela S., Gustafsson J.A., Dahiya R., Cunha G.R. Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-alpha knockout mouse. Biol. Reprod. 2001, 64:272-283.
30. Loven M.A., Wood J.R., Nardulli A.M. Interaction of estrogen receptors alpha and beta with estrogen response elements. Mol. Cell. Endocrinol. 2001, 181:151-163.
31. Malik G., Gorbounov N., Das S., Gurusamy N., Otani H., Maulik N., Goswami S., Das D.K. Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway. Antioxid. Redox Signal. 2006, 8:2101-2109.
32. Maruyama T., Sachi Y., Furuke K., Kitaoka Y., Kanzaki H., Yoshimura Y., Yodoi J. Induction of thioredoxin, a redox-active protein, by ovarian steroid hormones during growth and differentiation of endometrial stromal cells in vitro. Endocrinology 1999, 140:365-372.
33. Mol C.D., Izumi T., Mitra S., Tainer J.A. DNA-bound structures and mutants reveal abasic DNA binding by APE1 and DNA repair coordination [corrected]. Nature 2000, 403:451-456.
34. Nelson J.F., Felicio L.S., Osterburg H.H., Finch C.E. Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL/6J mice. Endocrinology 1992, 130:805-810.
35. Noda Y., Ota K., Shirasawa T., Shimizu T. Copper/zinc superoxide dismutase insufficiency impairs progesterone secretion and fertility in female mice. Biol. Reprod. 2012, 86:1-8.
36. Noiva R. Protein disulfide isomerase: the multifunctional redox chaperone of the endoplasmic reticulum. Semin. Cell Dev. Biol. 1999, 10:481-493.
37. Nordberg J., Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biol. Med. 2001, 31:1287-1312.
38. Ohba H., Harano T., Omura T. Biosynthesis and turnover of a microsomal protein disulfide isomerase in rat liver. J. Biochem. 1981, 89:901-907.
39. Ohwada M., Suzuki M., Sato I., Tsukamoto H., Watanabe K. Glutathione peroxidase activity in endometrium: effects of sex hormones and cancer. Gynecol. Oncol. 1996, 60:277-282.
40. Pejic S., Todorovic A., Stojiljkovic V., Kasapovic J., Pajovic S.B. Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma. Reprod. Biol. Endocrinol. 2009, 7:149.
41. Punnonen R., Kudo R., Punnonen K., Hietanen E., Kuoppala T., Kainulainen H., Sato K., Ahotupa M. Activities of antioxidant enzymes and lipid peroxidation in endometrial cancer. Eur. J. Cancer 1993, 29A:266-269.
42. Rao A.K., Ziegler Y.S., McLeod I.X., Yates J.R., Nardulli A.M. Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Mol. Endocrinol. 2008, 22:1113-1124.
43. Rao A.K., Ziegler Y.S., McLeod I.X., Yates J.R., Nardulli A.M. Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells. J. Mol. Endocrinol. 2009, 43:251-261.
44. Rao A.K., Dietrich A.K., Ziegler Y.S., Nardulli A.M. 17beta-Estradiol-mediated increase in Cu/Zn superoxide dismutase expression in the brain: a mechanism to protect neurons from ischemia. J. Steroid Biochem. Mol. Biol. 2011, 127:382-389.
45. Robertson K.A., Bullock H.A., Xu Y., Tritt R., Zimmerman E., Ulbright T.M., Foster R.S., Einhorn L.H., Kelley M.R. Altered expression of Ape1/Ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res. 2001, 61:2220-2225.
46. Sahlin L., Wang H., Masironi B., Holmgren A., Eriksson H. Regulation of thioredoxin mRNA in the rat uterus by gonadal steroids. J. Steroid Biochem. Mol. Biol. 1999, 68:203-209.
47. Sahlin L., Masironi B., Akerberg S., Eriksson H. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus. Reprod. Biol. Endocrinol. 2006, 4:47.
48. Schultz J.R., Loven M.A., Senkus Melvin V.M., Edwards D.P., Nardulli A.M. Differential modulation of DNA conformation by estrogen receptors {alpha} and {beta}. J. Biol. Chem. 2002, 277:8702-8707.
49. Schultz-Norton J.R., McDonald W.H., Yates J.R., Nardulli A.M. Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor alpha structure and function. Mol. Endocrinol. 2006, 20:1982-1995.
50. Schultz-Norton J.R., Ziegler Y.S., Nardulli A.M. ERalpha-associated protein networks. Trends Endocrinol. Metab. 2011, 22:124-129.
51. Shan W., Zhong W., Zhao R., Oberley T.D. Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression. Free Radical Biol. Med. 2010, 49:2078-2087.
52. Simons A.L., Parsons A.D., Foster K.A., Orcutt K.P., Fath M.A., Spitz D.R. Inhibition of glutathione and thioredoxin metabolism enhances sensitivity to perifosine in head and neck cancer cells. J. Oncol. 2009, 2009:519563.
53. Subbiah M.T.R. Mechanisms of cardioprotection by estrogens. Proc. Soc. Exp. Biol. Med. 1998, 217:23-29.
54. Sun Y., Rigas B. The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res. 2008, 68:8269-8277.
55. Sun Y., Rowehl L.M., Huang L., Mackenzie G.G., Vrankova K., Komninou D., Rigas B. Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system. Breast Cancer Res. 2012, 14:R20.
56. Tell G., Quadrifoglio F., Tiribelli C., Kelley M.R. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid. Redox Signal. 2009, 11:601-620.
57. Tinelli A., Vergara D., Martignago R., Leo G., Malvasi A., Tinelli R. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review. Acta Obstet. Gynecol. Scand. 2008, 87:1101-1113.
58. Toran-Allerand C. Mechanisms of estrogen action during neural development: mediation by interactions with the neurotophins and their receptors?. J. Steroid Biochem. Mol. Biol. 1996, 56:169-178.
59. Walker V.R., Korach K.S. Estrogen receptor knockout mice as a model for endocrine research. ILAR J. 2004, 45:455-461.
60. Webster K.A., Prentice H., Bishopric N.H. Oxidation of zinc finger transcription factors: physiological consequences. Antioxid. Redox Signal. 2001, 3:535-548.
61. Weydert C.J., Waugh T.A., Ritchie J.M., Iyer K.S., Smith J.L., Li L., Spitz D.R., Oberley L.W. Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radical Biol. Med. 2006, 41:226-237.
62. Wilkinson B., Gilbert H.F. Protein disulfide isomerase. Biochim. Biophys. Acta 2004, 1699:35-44.
63. Wise P.M., Camp-Grossman P., Barraclough C.A. Effects of estradiol and progesterone on plasma gonadotropins, prolactin, and LHRH in specific brain areas of ovariectomized rats. Biol. Reprod. 1981, 24:820-830.
64. Wood J.R., Greene G.L., Nardulli A.M. Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol. Cell. Biol. 1998, 18:1927-1934.
65. Wood J.R., Likhite V.S., Loven M.A., Nardulli A.M. Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol. Endocrinol. 2001, 15(7):1114-1126.
66. Zelko I.N., Mariani T.J., Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radical Biol. Med. 2002, 33:337-349.
67. Zhang Y., Wang J., Xiang D., Wang D., Xin X. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and identification of the therapeutic potential of APE1/Ref-1 inhibitor. Int. J. Oncol. 2009, 35:1069-1079.